415 related articles for article (PubMed ID: 29224003)
1. Human Leukocyte Antigen-G Inhibits the Anti-Tumor Effect of Natural Killer Cells via Immunoglobulin-Like Transcript 2 in Gastric Cancer.
Wan R; Wang ZW; Li H; Peng XD; Liu GY; Ou JM; Cheng AQ
Cell Physiol Biochem; 2017; 44(5):1828-1841. PubMed ID: 29224003
[TBL] [Abstract][Full Text] [Related]
2. Rescuing lymphocytes from HLA-G immunosuppressive effects mediated by the tumor microenvironment.
Wu D; Kuiaste I; Moreau P; Carosella E; Yotnda P
Oncotarget; 2015 Nov; 6(35):37385-97. PubMed ID: 26460949
[TBL] [Abstract][Full Text] [Related]
3. HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j.
Morel E; Bellón T
J Immunol; 2008 Aug; 181(4):2368-81. PubMed ID: 18684926
[TBL] [Abstract][Full Text] [Related]
4. Cytometry-based analysis of HLA-G functions according to ILT2 expression.
Jacquier A; Dumont C; Carosella ED; Rouas-Freiss N; LeMaoult J
Hum Immunol; 2020 Apr; 81(4):168-177. PubMed ID: 32081570
[TBL] [Abstract][Full Text] [Related]
5. β2-Microglobulin-free HLA-G activates natural killer cells by increasing cytotoxicity and proinflammatory cytokine production.
Zhao L; Purandare B; Zhang J; Hantash BM
Hum Immunol; 2013 Apr; 74(4):417-24. PubMed ID: 23228393
[TBL] [Abstract][Full Text] [Related]
6. Killer Ig-like receptor 2DL4 does not mediate NK cell IFN-γ responses to soluble HLA-G preparations.
Le Page ME; Goodridge JP; John E; Christiansen FT; Witt CS
J Immunol; 2014 Jan; 192(2):732-40. PubMed ID: 24337374
[TBL] [Abstract][Full Text] [Related]
7. A Phenotypic Analysis of Regulatory T Cells and Uterine NK Cells from First Trimester Pregnancies and Associations with HLA-G.
Djurisic S; Skibsted L; Hviid TV
Am J Reprod Immunol; 2015 Nov; 74(5):427-44. PubMed ID: 26293482
[TBL] [Abstract][Full Text] [Related]
8. Interaction between HLA-G and NK cell receptor KIR2DL4 orchestrates HER2-positive breast cancer resistance to trastuzumab.
Zheng G; Guo Z; Li W; Xi W; Zuo B; Zhang R; Wen W; Yang AG; Jia L
Signal Transduct Target Ther; 2021 Jun; 6(1):236. PubMed ID: 34158475
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human gamma delta [corrected] T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer.
Lesport E; Baudhuin J; Sousa S; LeMaoult J; Zamborlini A; Rouas-Freiss N; Carosella ED; Favier B
Cell Mol Life Sci; 2011 Oct; 68(20):3385-99. PubMed ID: 21337044
[TBL] [Abstract][Full Text] [Related]
10. HLA-G1
Rao JS; Hosny N; Kumbha R; Naqvi RA; Singh A; Swanson Z; Levy H; Matson AW; Steinhoff M; Forneris N; Walters E; Hering BJ; Burlak C
Front Immunol; 2021; 12():730545. PubMed ID: 34566993
[TBL] [Abstract][Full Text] [Related]
11. The Killer Cell Ig-like Receptor 2DL4 Expression in Human Mast Cells and Its Potential Role in Breast Cancer Invasion.
Ueshima C; Kataoka TR; Hirata M; Furuhata A; Suzuki E; Toi M; Tsuruyama T; Okayama Y; Haga H
Cancer Immunol Res; 2015 Aug; 3(8):871-80. PubMed ID: 25735953
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting HLA-G restores IFN-γ and TNF-α producing T cell in pleural Tuberculosis.
Saurabh A; Chakraborty S; Kumar P; Mohan A; Bhatnagar AK; Rishi N; Mitra DK
Tuberculosis (Edinb); 2018 Mar; 109():69-79. PubMed ID: 29559123
[TBL] [Abstract][Full Text] [Related]
13. RNA interfering targeting human leukocyte antigen-G enhanced immune surveillance mediated by the natural killer cells on hepatocellular carcinoma.
Zeng XC; Zhang T; Huang DH; Wang GY; Chen W; Li H; Zhang J; Fang TL; Zhang Q; Chen GH
Ann Clin Lab Sci; 2013; 43(2):135-44. PubMed ID: 23694787
[TBL] [Abstract][Full Text] [Related]
14. Changes of inhibitory receptors on NK-92 cells and HLA-G on BeWo cells with Toxoplasma gondii infection.
Liu Y; Zhang L; Gao M; Zhang F; Xu X; Liu X; Hu X
Inflammation; 2013 Dec; 36(6):1440-7. PubMed ID: 23872718
[TBL] [Abstract][Full Text] [Related]
15. First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G.
Anna F; Bole-Richard E; LeMaoult J; Escande M; Lecomte M; Certoux JM; Souque P; Garnache F; Adotevi O; Langlade-Demoyen P; Loustau M; Caumartin J
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737343
[TBL] [Abstract][Full Text] [Related]
16. Human M2 Macrophages Limit NK Cell Effector Functions through Secretion of TGF-β and Engagement of CD85j.
Nuñez SY; Ziblat A; Secchiari F; Torres NI; Sierra JM; Raffo Iraolagoitia XL; Araya RE; Domaica CI; Fuertes MB; Zwirner NW
J Immunol; 2018 Feb; 200(3):1008-1015. PubMed ID: 29282306
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of iNKT Cells by the HLA-G-ILT2 Checkpoint and Poor Stimulation by HLA-G-Expressing Tolerogenic DC.
Wu CL; Caumartin J; Amodio G; Anna F; Loustau M; Gregori S; Langlade-Demoyen P; LeMaoult J
Front Immunol; 2020; 11():608614. PubMed ID: 33505397
[TBL] [Abstract][Full Text] [Related]
18. ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse.
Favier B; Lemaoult J; Lesport E; Carosella ED
FASEB J; 2010 Mar; 24(3):689-99. PubMed ID: 19841038
[TBL] [Abstract][Full Text] [Related]
19. Gastric cancer-derived heat shock protein-gp96 peptide complex enhances dendritic cell activation.
Lu WW; Zhang H; Li YM; Ji F
World J Gastroenterol; 2017 Jun; 23(24):4390-4398. PubMed ID: 28706421
[TBL] [Abstract][Full Text] [Related]
20. Expression of immunoglobulin-like transcript (ILT)2 and ILT3 in human gastric cancer and its clinical significance.
Zhang Y; Lu N; Xue Y; Zhang M; Li Y; Si Y; Bian X; Jia Y; Wang Y
Mol Med Rep; 2012 Apr; 5(4):910-6. PubMed ID: 22246571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
